metformin,enzalutamide
astellas,Pfizer
['congrat', 'metformin ', 'prostate', 'crpc']
no improvement of outcomes with the addition of metformin to adt/enza in mcrpc #prostatecancer patients. non conclusive study but congrats to the sakk group #esmo22 
Full Prof Radiation Oncology @gustaveroussy @UnivParisSaclay. EiC https://t.co/ZZv4fFrcCi. Director @SciencesCancer. Adjunct Assoc Prof @MDAndersonNews.